tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Aldeyra Therapeutics: Strategic Pipeline Advancements and Financial Stability Drive Buy Rating
RatingsAldeyra Therapeutics: Strategic Pipeline Advancements and Financial Stability Drive Buy Rating
5d ago
ALDX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
6d ago
ADMA
ALDX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7d ago
ALDX
ANRO
Optimistic Buy Rating for Aldeyra Therapeutics Amid Promising FDA Review and Potential AbbVie Collaboration
PremiumRatings
Optimistic Buy Rating for Aldeyra Therapeutics Amid Promising FDA Review and Potential AbbVie Collaboration
9d ago
ALDX
Oppenheimer pharmaceuticals analysts hold analyst/industry conference call
PremiumThe Fly
Oppenheimer pharmaceuticals analysts hold analyst/industry conference call
3M ago
ALDX
Aldeyra says FDA accepts reproxalap NDA, AbbVie deal expanded to $100M
PremiumThe FlyAldeyra says FDA accepts reproxalap NDA, AbbVie deal expanded to $100M
4M ago
ALDX
Aldeyra resubmits topical ocular reproxalap NDA to FDA
Premium
The Fly
Aldeyra resubmits topical ocular reproxalap NDA to FDA
5M ago
ALDX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
ABUS
ALDX
Aldeyra Therapeutics Announces Executive Team Changes
PremiumCompany Announcements
Aldeyra Therapeutics Announces Executive Team Changes
6M ago
8K
ALDX
Aldeyra Therapeutics Announces Major Dry Eye Treatment Success
PremiumCompany Announcements
Aldeyra Therapeutics Announces Major Dry Eye Treatment Success
7M ago
8K
ALDX
Aldeyra announces advancement of new RASP modulators, preclinical data
PremiumThe Fly
Aldeyra announces advancement of new RASP modulators, preclinical data
9M ago
ALDX
Aldeyra Therapeutics Completes Phase 3 Trial Enrollment for Reproxalap
PremiumCompany Announcements
Aldeyra Therapeutics Completes Phase 3 Trial Enrollment for Reproxalap
9M ago
8K
ALDX
Aldeyra completes enrollment in reproxalap trial
PremiumThe FlyAldeyra completes enrollment in reproxalap trial
9M ago
ALDX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
EQ
VIR
Aldeyra enrolls first patient in dry eye chamber clinical trial
Premium
The Fly
Aldeyra enrolls first patient in dry eye chamber clinical trial
10M ago
ALDX
Aldeyra Therapeutics Unveils R&D Progress and Goals
PremiumCompany Announcements
Aldeyra Therapeutics Unveils R&D Progress and Goals
11M ago
8K
ALDX
Fly Insider: Xilio, Aerovate among week’s notable insider trades
PremiumThe Fly
Fly Insider: Xilio, Aerovate among week’s notable insider trades
11M ago
XLO
ALDX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
11M ago
ABIO
ABUS
Oppenheimer more bullish on Aldeyra, upgrades to Outperform
PremiumThe Fly
Oppenheimer more bullish on Aldeyra, upgrades to Outperform
11M ago
ABBV
ALDX
Aldeyra upgraded to Outperform from Perform at Oppenheimer
PremiumThe FlyAldeyra upgraded to Outperform from Perform at Oppenheimer
11M ago
ALDX
Aldeyra in FDA clinical plan for NDA resubmission of reproxalap for DED
Premium
The Fly
Aldeyra in FDA clinical plan for NDA resubmission of reproxalap for DED
12M ago
ALDX
Aldeyra Therapeutics Unveils Reproxalap Development Update
Premium
Company Announcements
Aldeyra Therapeutics Unveils Reproxalap Development Update
12M ago
8K
ALDX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >